DİŞ HEKİMLİĞİNDE GEN TEDAVİSİ (DERLEME)

Year 2019, Volume: 29 Issue: 4, 691 - 700, 15.10.2019

Yelda Kasımoğlu , Mine Koruyucu Figen Seymen

https://doi.org/10.17567/ataunidfd.443195

Cited By: 1

Abstract

Biyoteknoloji
alanındaki gelişmeler, medikal araştırmalarda gen tedavisini ön plana çıkarmış
ve günümüz genetik prensiplerinin ağız diş sağlığını geliştirmek için
kullanılmasına yol açmıştır. Bu yeni teknolojilerinin diş hekimliği ile
buluşmasını; restoratif biyometaryallerin üretiminde kaydedilen bilimsel
aşamalar, doku mühendisliği, moleküler biyolojinin kullanımı ve insan genom
projesi sağlamıştır. Gen tedavisi, defektli genin özel bir yöntem kullanılarak tedavi
edici bir gen ile değiştirilmesi veya tamir edilmesidir. Birçok hastalığın
tedavisinde ve genetik bozuklukların düzeltilmesinde kullanılabilmektedir. Gen
tedavisinin diş hekimliğinde dentofasiyal uygulama alanları arasında kemik
rejenerasyonu, DNA bazlı immunizasyon (çürük ve periodontal hastalıklar), ağrı
tedavisi, otoimmun hastalıkların tedavisi ve kanser tedavisi yer almaktadır.
Genel olarak araştırmalarda yeni vektör sistemlerinin ve taşıma metotlarının
geliştirilmesi, bunların test edilmesi, vektör transdüksiyonunu içeren
mekanizmaların açıklığa kavuşturulması ve en iyi sonuç verebilecek
yaklaşımların klinik deneylerde kullanılmasına çalışılmaktadır. Geçtiğimiz 15
yılda gen ve ilaç taşıyıcı sistemler için çeşitli vektörler geliştirilmeye
çalışılmıştır. Gen tedavisi, diş hekimliği alanında bilimsel bazda önemli
etkiye sahiptir. Bu derlemede gen tedavisi metotları, ilgili vektörler, gen
tedavisinin diş hekimliğinde klinik etkisi ve konuya ilişkin bilimsel bilgilerin
güncellenmesi amaçlanmıştır.

Anahtar Kelimeler:
diş
hekimliği, genetik, gen tedavisi, genetik vektörler

 

GENE THERAPY IN DENTISTRY (REVIEW) 

ABSTRACT

Advances in
biotechnology have brought gene therapy to a very important and
active area of medical research and currently genetic principles are being applied along to improve oral
health. Scientific advances in restorative biomaterials, tissue
engineering, molecular biology and the human genome project provide the
basis for the introduction of new technologies into dentistry. Gene therapy is
a particular method by which missing or defective genes are replaced or
repaired by normal genes. It can be used to treat wide range of diseases and
correct genetics disorders. In dentistry the application of gene therapy to dentofacial
problems includes bone regeneration, DNA based immunization (for caries and
periodontal disease), pain, for treating auto immune disease and cancer. The
general approach is to develop new vector systems and delivery methods, test
them, uncover the mechanisms involved in vector transduction, and use the most
promising approaches in clinical trials. For the past 15 years various vectors
have been designed for improved gene and drug delivery. This field is having
significant impact on topics related to dental practice. The aim of this
review is to provide an update on gene therapy methods, its clinical
implication in dentistry and scientific information associated with gene
therapy.

Key Words: dentistry; genetics;
gene therapy; genetic vectors

Keywords

diş hekimliği, genetik, gen tedavisi

References

• 1. Miller DA. Human gene therapy comes of age. Nature 1992;375:455-60.
• 2. Friedmann T, Robin R. Gene therapy for human genetic disease? Science 1972;175:949-55.
• 3. Bayertz K, Paslack R, Schmidt KW. Summary of gene transfer into human somatic cells, state of the technology, medical risks, social and ethical problems: a report. Hum Gene Ther. 1994;5:465–8.
• 4. Al-Dosari MS, Gao X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS 2009;11(4):671-681.
• 5. Garcia-Godoy F, Murray P. Regenerative dentistry: translating advancements in basic science research to the dental practice. J Tenn Dent Assoc. 2010;90(4):12-18.
• 6. Yayla M, Gül T, Görmüş H, Nazaroğlu H, Erden AC. Dicle Üniversitesi Tıp Fakültesi’ndeki doğumlarda konjenital anomali prevalansı: 6 yıllık seri. Zeynep Kamil Tıp Bülteni 1997;29(3-4):176-181.
• 7. Misra S. Human gene therapy: a brief overview of the genetic revolution. JAPI 2013;61:127-133.
• 8. Razi Soofiyani S, Baradaran B, Lotfipour F, Kazemi T, Mohammadnejad L. Gene therapy, early promises, subsequent problems, and recent breakthroughs. Adv Pharm Bull. 2013;3(2):249-55.
• 9. Matthews QL, Curiel DT. Gene therapy human germline genetics modifications-assessing the scientific, socioethical, and religious issues. South Med J. 2007;100:98-100.
• 10. Günel Özcan A. Gen tedavisi ve biyogüvenlik. Türk Hijyen ve Deneysel Biyoloji Dergisi 2007;64(1):35-50.
• 11. Gupta K, Singh S, Garg KN. Gene therapy in dentistry: Tool of genetic engineering. Revisited. Arch Oral Biol. 2015;60:439-46.
• 12. Soofiyani SR, Baradaran B, Lotfipour F, Kazemi T, Mohammadnejad L. Gene therapy, early promises, subsequent problems, and recent breakthroughs. Adv Pharm Bull. 2013;3(2):249-255.
• 13. Gardlik R, Paiffy R, Hodosy J, Lukacs J, Twrna J, Celec P. Vectors and delivery system in gene therapy. Med Sci Monit. 2005;11:110-21.
• 14. Walter W, Stein U. Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs 2000;60(2):249-71.
• 15. Manjila SB, Baby JN, Bijin EN, Constantine I, Pramod K, Valsalakumari J. Novel gene delivery systems. Int J Pharm Investig. 2013;3(1):1-7.
• 16. Baun C, Dullman J, Li Z, Fehse B, Meyer J, Williams DA, et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003;101:2099-114.
• 17. Wolff JA, Malone RW, Williams P, Chong W, Aesadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465–8.
• 18. Pierce EA, Liu Q, Igouchera O, Dmarrudin R, Ma H, Diamond SL, et al. Oligonucleotide-directed single base DNA alteration in mouse embryonic stem cells. Gene Ther. 2003;10:24-33.
• 19. Caplen NJ, Alton EW, Middleton PG, Dorin JR, Stevenson BJ, Gao X, et al. Liposome mediated CFTR gene transfer to a nasal epithelium of patient with cystic fibrosis. Nat Med. 1995;1:39-46.
• 20. Huang S, Kamihira M. Development of hybrid viral vectors for gene therapy. Biotechnol Adv. 2013;31(2):208-23.
• 21. Chaplot SP, Rupenthal ID. Dendrimers for gene delivery – a potential approach for ocular therapy? J Pharm Pharmacol. 2014;66(4):542-56.
• 22. Kamimura K, Suda T, Zhang G, Liu D. Advances in gene delivery systems. Pharmaceut Med. 2011;25(5):293-306.
• 23. Kudyar N, Dani N, Mahale S. Periodontal vaccine: a dream or reality. J Indian Soc Periodontol. 2011;15(2):115-120.
• 24. Nakashima M, Tachibana K, Iohara K, Ito M, Ishikawa M, Akamine A. Induction of reparative dentin formation by ultrasound-mediated gene delivery of growth/differentiation factor 11. Hum Gene Ther. 2003;14:591–7.
• 25. Scheller EL, Krebsbach PH. Gene therapy: design and prospects for craniofacial regeneration. J Dent Res. 2009;88(7):585-596.
• 26. Özcan E, Atuğ Özcan SS. Periodontal rejenerasyonda kök hücrenin yeri. J Dent Fac Atatürk Uni 2010;20(2):123-130.
• 27. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E, et al. Combined bone morphogenetic protein-2 and - 7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res. 2004;19:2021-32.
• 28. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am. 2003;85A:1544-52.
• 29. Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT. In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res. 2003;18:705-15.
• 30. Anusaksathien O, Jin Q, Zhao M, Somerman MJ, Giannobile WV. Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum. J Periodontol. 2004;75(3):429-40.
• 31. Jin Q, Anusaksathien O, Webb SA, Printz MA, Giannobile WV. Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther. 2004;9(4):519-526.
• 32. Kaigler D, Mooney D. Tissue engineering’s impact on dentistry. J Dent Educ. 2001;65(5):456-62.
• 33. Dunn CA, Jin Q, Taba M Jr, Franceschi RT, Bruce Rutherford R, Giannobile WV. BMP gene delivery for alveolar bone engineering dental implant defects. Mol Ther. 2005;11(2):294-9.
• 34. Chatterjee A, Singh N, Saluja M. Gene therapy in periodontics J Indian Soc Periodontol. 2013;17(2):156-161.
• 35. Fliefel R, Kühnisch J, Efrenfeld M, Otto S. Gene therapy for bone defects in oral and maxillofacial surgery: a systematic review and meta-analysis of animal studies. Stem Cells Dev 2017;26(4):215-230.
• 36. Okawa R, Iijima O, Kishino M, Okawa H, Toyosawa S, Sugano-Tajima H, Shimada T, Okada T, Ozono K, Ooshima T, Nakano K. Gene therapy improves dental manifestations in hypophosphatasia model mice. J Periodontal Res 2017;52(3):471-478.
• 37. Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization. Annu Rev Biochem. 2000;18:927-974.
• 38. Barackman JD, Ott G, O’Hagan DT. Intranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induced potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization. Infection and Immunity 1999;67(8):4276-4279.
• 39. Zhou X, Zhang X, Yu X, Zha X, Fu Q, Liu B, et al. The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine. Biomaterials 2008;29(1):111-7.
• 40. Wang X, Zhang X, Kang Y, Jin H, Du X, Zhao G, et al. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus. Vaccine 2008;26(40):5135-44.
• 41. Khatri K, Goyal AK, Gupta PN, Mishra N, Mehta A, Vyas SP. Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine 2008;26(18):2225-33.
• 42. Chen L, Zhu J, Li Y, Lu J, Gao L, Xu H, et al. Enhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan/DNA complexes. PLoS One 2013;8(8):e71953.
• 43. Waterhouse JC, Russell RR. Dispensable genes and foreign DNA in Streptococcus mutans. Microbiology 2006;152(6):1777-88.
• 44. Cui Z. DNA vaccine. Adv Genet. 2005;54:257-89.
• 45. Coombes BK, Mahony JB. Dendritic cell discoveries provide new insight into the cellular immunobiology of DNA vaccines. Immunol Lett. 2001;78(2):103-11.
• 46. Liu S, Gong Q, Wang C, Liu H, Wang Y, Guo S, et al. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice. Immunol Lett. 2008;117(2):136-45.
• 47. Xu QA, Yu F, Fan MW, Bian Z, Chen Z, Fan B, et al. Immunogenicity and persistence of a targeted anti-caries DNA vaccine. J Dent Res. 2006;85(10):915-8.
• 48. Liu S, Chen P, Hu M, Tao Y, Chen L, Liu H, et al. Randomized, controlled phase II study of post-surgery radiotherapy combined with recombinant adenoviral human p53 gene therapy in treatment of oral cancer. Cancer Gene Ther. 2013;20(6):375-8.
• 49. Mcwilliams JE, Evans AJ, Beer TM, Anderson PE, Cohen JI, Everts EC, et al. Genetic polymorphisms in head and neck cancer risk. Head Neck 2000;22:609-17.
• 50. Searle PF, Chen MJ, Hu L, Race PR, Lovering AL, Grove JI, et al. Nitroreductase: a prodrug-activating enzyme for cancer gene therapy. Clin Exp Pharmacol Physiol. 2004;31:811-6.
• 51. Kershaw MH, Teng MW, Smyth MJ. Supernatural T cells: genetic modification of T cells for cancer therapy. Nat Rev Immunol. 2005;5:928-40.
• 52. Steel JC, Di Pasquale G, Ramiogan CA, Patel V, Chiorini JA, Morris JC. Oral vaccination with adeno-associated virus vectors expressing the Neu oncogene inhibits the growth of murine breast cancer. Mol Ther. 2013;21(3):680-7.
• 53. Singh R, Singh S, Kumar T, Kumar A, Kumar A, Nazeer J. A novel approach in the treatment of oral cancer-gene therapy an update. World J Pharm Pharm Sci 2017;6(4):283-289.
• 54. Aframian DJ, Palmon A (2008). Current status of the development of an artificial salivary gland. Tissue Eng Part B Rev. 2008;14:187-198.
• 55. Cotrim AP, Mineshiba F, Sugito T, Samuni Y, Baum BJ. Salivary gland gene therapy. Dent Clin North Am. 2006;50(2):157–73.
• 56. Geguchadze R, Wang Z, Zourelias L, Perez-Riveros P, Edwards PC, Machen L, Passineau MJ. Proteomic profiling of salivary gland after nonviral gene transfer mediated by conventional plasmids and minicircles. Mol Ther Methods Clin Dev. 2014;1:14007.
• 57. Paramel Mohan Sunil, Ramachandran CR, Jaisanghar N, Santhosh Kumar C. Dental surgeons as gene therapist. Int J Oral Maxillofac Pathol. 2012;3(3):65-67.
• 58. Jonathan CV. Keratinocyte gene therapy. Arch Dermatol. 1993;129:1478-83.
• 59. Tzabazis AZ, Klukinov M, Feliciano DP, Wilson SP, Yeomans DC. Gene therapy for trigeminal pain in mice. Gene Therapy 2014;21:422-426.